Filing Details
- Accession Number:
- 0001127602-11-027952
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-10-31 15:39:43
- Reporting Period:
- 2011-10-27
- Filing Date:
- 2011-10-31
- Accepted Time:
- 2011-10-31 15:39:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222679 | E Michael Prevoznik | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-27 | 68,000 | $35.53 | 109,058 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-27 | 68,000 | $56.68 | 41,058 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-10-27 | 48,000 | $48.74 | 89,058 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-27 | 48,000 | $56.68 | 41,058 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-10-27 | 68,000 | $0.00 | 68,000 | $35.53 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2011-10-27 | 48,000 | $0.00 | 48,000 | $48.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-04-17 | 2012-02-27 | No | 4 | M | Direct |
| 0 | 2008-02-22 | 2012-02-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,332 | Indirect | 401k/SDCP |
Footnotes
- The option vests in three equal annual installments beginning on the anniversary date of the grant.
- The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 7, 2011.
- This transaction was executed in multiple trades at prices ranging from $56.45 to $56.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Due to circumstances beyond the control of the Reporting Person, these holdings have not been updated to reflect exempt acquisitions that have occurred since the date of the Reporting Person's most recently filed Form 4. The holdings will be updated on the next Form 4 filed by the Reporting Person
Billionaire Hedge Funds
